PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (March 06 - 10, 2023)

PharmaShots Weekly Snapshots (March 06 - 10, 2023)

March 10, 2023

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes

March 10, 2023

Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies

Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies

March 10, 2023

BerGenBio Reports the First Patient Dosing of Bemcentinib in the P-Ib/IIa Trial as 1L Treatment of Non-Small Cell Lung Cancer

BerGenBio Reports the First Patient Dosing of Bemcentinib in the P-Ib/IIa Trial as 1L Treatment of Non-Small Cell Lung Cancer

March 10, 2023

AstraZeneca Reports P-III Trial (AEGEAN) Results of Imfinzi (durvalumab) for Non-Small Cell Lung Cancer

AstraZeneca Reports P-III Trial (AEGEAN) Results of Imfinzi (durvalumab) for Non-Small Cell Lung Cancer

March 10, 2023

Astellas and Seagen Report the NMPA’s Acceptance of BLA for Enfortumab Vedotin to Treat Urothelial Cancer

Astellas and Seagen Report the NMPA’s Acceptance of BLA for Enfortumab Vedotin to Treat Urothelial Cancer

March 10, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us